At-Home Magnetic Therapy for Thinking and Memory Problems After Brain Injury
Tests an at-home magnetic therapy device in people with cognitive problems.
Plain-language title generated from the registry record
Registry title: Fareon Open Label Device Clinical Trial
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)New York, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Trial code
- NCT07600320
- Record updated
- 28 October 2026
- Original description
The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.Read full original descriptionShow less
Microtesla Magnetic Therapy (MMT) Treatment of Cognitive Impairment: Open Label Pilot Study
The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.
Exclusion: Change in anti-depressant or other psychoactive medication or dose in the last 90 days; Any medical, psychiatric, or neurological condition, or concurrent treatment, that in the opinion of the Principal Investigator would interfere with study participation, interpretation of results, or pose additional risk to the participant; History of seizure disorder; Individual who meets any of the following criteria will be excluded from participation in this study:; Enrollment in another interventional clinical trial in the last 90 days or during the study period; Cranially implanted devices or metal; Pacemaker; Pregnant or plan to become pregnant during the study as indicated by proof of a positive pregnancy test; Inability to achieve appropriate positioning of the study device on the head.
IncInclusion Criteria:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:; Any sex/gender; 16 years of age or older; English Speaking; Experiencing symptoms of at least self-reported mild cognitive impairment associated with a confirmed diagnosis of a condition such as Long COVID, Traumatic Brain Injury, other Acquired Brain Injuries, and other neurodegenerative diagnoses including but not limited to Alzheimer's disease; Individuals of childbearing age agreeing to use a highly effective form of birth control for the duration of their participation; Willing and able to sign informed consent or have a parent or LAR able to sign informed consent form; Willing and able to attend all study visits virtually or in person.